Transcept Pharmaceuticals (TSPT) said Tuesday that it has appointed Thomas Soloway as the executive vice president and chief operating officer.
Soloway joined Transcept as a co-founder in 2002 and served previously as Senior Vice President, Operations and Chief Financial Officer prior to this promotion.
All senior executives of the company, except Chief Scientific Officer and Co-Founder Nikhilesh Singh, will hereafter report to Soloway. Singh will continue to report to President and Chief Executive Officer Glenn Oclassen.
For comments and feedback: editorial@rttnews.com